Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Drugs and Breast Milk Research Released


Drugs and Breast Milk

The Department of Clinical Pharmacology at Otago University’s Christchurch School of Medicine and Health Sciences, and Christchurch Hospital has released its latest research into drugs and breast milk. The Department has a long-standing interest in the impact of drugs on babies ingesting breast milk from mothers on medication, and this further study extends this investigation.

The focus of the latest research is the drug metformin, often used in the management of type 2 diabetes, and polycystic ovary syndrome. There has been concern about the possible transfer of the drug to breastfeeding babies if their mother is on this drug, and to what extent the baby absorbs metformin through breast milk.

The study has been carried out in association with the Canterbury DHB Diabetes Centre and the School of Pharmacy, University of Otago, and has been submitted by Sharon Gardiner for her Masters of Clinical Pharmacy degree.

“What this study reveals is that although the baby is exposed to some metformin, the amount is well below the level where clinicians and mothers need to be concerned,” says Professor Evan Begg, head of the Clinical Pharmacology Department. “Our tests with mothers and babies have revealed for the first time that babies ingested metformin at just 0.2% of the maternal dose, after correction for body weight. This is well below the 10% safety threshold.”

The method used to determine exposure to a drug like metformin is by measuring its level in the blood of the mother and baby, and also in breast milk. Although metformin was found in breast milk, no adverse effects were observed in the three babies who were exposed to metformin in milk, and the drug could not be detected in the blood of the two babies who were tested.

One of the other interesting aspects is that modelling indicated there should be much higher concentrations of metformin in breast milk than was actually the case. This suggests there may be some unusual mechanism that keeps metformin out of milk. This is now being investigated.

This result adds to other research into drugs and breast milk in the Department. Studies of other drugs, such as quinapril, paroxetine and olanzapine, have indicated the transfer of these medications to babies through breast feeding is below the clinical safety levels. For some other drugs such as fluoxetine (Prozac), drug transfer may be above the usual safety limits, and breastfeeding is not recommended.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Voluntary Administration: Renaissance Brewing Up For Sale

Renaissance Brewing, the first local company to raise capital through equity crowdfunding, is up for sale after cash flow woes and product management issues led to the appointment of voluntary administrators. More>>

Elsewhere:

Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:

Media Mega Merger: Full Steam Ahead For Appeal

New Zealand's two largest news publishers have confirmed they are committed to pursuing their appeal against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>